Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
172 <strong>Annual</strong> Financial Statement Konzern-Jahresabschluss<br />
Meditec Pharma Others / consolidations<br />
<strong>biolitec</strong> group<br />
and transitions<br />
July 1 –June 30 July 1 –June 30 July 1 –June 30 July 1 –June 30<br />
K Euro <strong>2009</strong> / <strong>2010</strong> 2008 / <strong>2009</strong> <strong>2009</strong> / <strong>2010</strong> 2008 / <strong>2009</strong> <strong>2009</strong> / <strong>2010</strong> 2008 / <strong>2009</strong> <strong>2009</strong> / <strong>2010</strong> 2008 / <strong>2009</strong><br />
External revenues 28,798 28,747 1,586 1,772 0 0 30,384 30,519<br />
0 0 0 0 0 0 0 0<br />
Intersegmentary<br />
revenues<br />
28,798 28,747 1,586 1,772 0 0 30,384 30,519<br />
Total segment<br />
result<br />
(22,383) (26,111) (3,423) (4,041) 0 0 (25,807) (30,151)<br />
Functional costs<br />
before depreciation<br />
and amortization<br />
(3,705) (2,327) (601) (622) 0 0 (4,306) (2,949)<br />
Depreciation and<br />
amortization<br />
Depletion (316) 0 0 0 0 0 (316) 0<br />
Goodwill (14) 1,388 16 42 0 0 2 1,431<br />
Income tax 118 186 0 2 (49) 0 70 188<br />
Interest Income (270) (288) (47) (2) 43 (106) (274) (395)<br />
Segment result 2,227 1,596 (2,469) (2,847) (6) (106) (247) (1,357)<br />
55 0 (1,132) 0 0 0 (1,077) 0<br />
Deconsolidation<br />
result<br />
Segment assets 101,452 91,993 25,311 23,589 (65,652) (54,279) 61,111 61,303<br />
Segment liabilities 28,781 23,820 1,049 2,705 (25,622) (22,239) 4,208 4,286
Change language